Inventor · disambiguated record
Frank Comer
Also filed as: COMER FRANK · COMER FRANK IRVINE
6 granted patents·6 pending applications·19 citations·filing 1998–2024
75Inventor score
Files withWELLSTAT VACCINES LLC6ASTRAZENECA AB2FUSION PHARMACEUTICALS INC2MEDIMMUNE LLC1SYNCOR INT CORPORATION1
Top patents by PatentIndex Score
12 records- 0174US10752704B2Antibodies targeted to fungal cell wall polysaccharidesWELLSTAT VACCINES LLC·Filed 2019·Granted Aug 25, 2020·0 cites·20 claims
- 0272USD425197SNeedle reinsertion device for use with medical syringesSYNCOR INT CORPORATION·Filed 1998·Granted May 16, 2000·19 cites·1 claims
- 0372US2024360226A1Antibody molecules and conjugatesASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0471US12065496B2Antibody molecules and conjugatesASTRAZENECA AB·Filed 2022·Granted Aug 20, 2024·0 cites·27 claims
- 0570US10988552B2Antibodies targeted to fungal cell wall polysaccharidesWELLSTAT VACCINES LLC·Filed 2020·Granted Apr 27, 2021·0 cites·3 claims
- 0670US2021301037A1Antibodies Targeted to Fungal Cell Wall PolysaccharidesWELLSTAT VACCINES LLC·Filed 2021·Application pending·0 cites
- 0765US10519253B2Antibodies targeted to fungal cell wall polysaccharidesWELLSTAT VACCINES LLC·Filed 2019·Granted Dec 31, 2019·0 cites·22 claims
- 0860US10259888B2Antibodies targeted to fungal cell wall polysaccharidesWELLSTAT VACCINES LLC·Filed 2017·Granted Apr 16, 2019·0 cites·19 claims
- 0960US2025041435A1Steap2 antibody drug conjugates and uses thereofMEDIMMUNE LLC·Filed 2024·Application pending·0 cites
- 1059US2016017062A1Antibodies targeted to fungal cell wall polysaccharidesWELLSTAT VACCINES LLC·Filed 2014·Application pending·0 cites
- 1159US2024350682A1Steap2-targeted compounds and use thereofFUSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1254US2025121104A1Egfr-cmet-targeted compounds and uses thereofFUSION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Frank Comer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →